MAPT and Alzheimer disease: The monoclonal antibody AT8, which recognizes phospho-serine 202 and phospho-threonine 205 on aggregated tau protein, is a principal tool to define AD intraneuronal pathology (pretangles and neurofibrillary tangles) [33].